Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

John Corboy

Concepts (393)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Sclerosis
50
2025
484
8.340
 Why?
Multiple Sclerosis, Relapsing-Remitting
15
2025
82
3.550
 Why?
Immunologic Factors
13
2025
255
2.420
 Why?
Neurology
10
2018
112
2.180
 Why?
Immunosuppressive Agents
10
2024
846
1.540
 Why?
Neuromyelitis Optica
4
2023
138
1.080
 Why?
Natalizumab
11
2021
41
0.900
 Why?
Recurrence
8
2025
1135
0.850
 Why?
Diagnostic Errors
2
2017
175
0.680
 Why?
Brain
16
2025
2933
0.650
 Why?
Internship and Residency
5
2011
1257
0.610
 Why?
Drug Substitution
2
2019
63
0.610
 Why?
Fingolimod Hydrochloride
5
2020
39
0.610
 Why?
Data Collection
4
2011
633
0.570
 Why?
Rituximab
4
2020
209
0.570
 Why?
Magnetic Resonance Imaging
25
2026
3863
0.570
 Why?
Dementia, Vascular
3
2009
21
0.560
 Why?
Medication Adherence
2
2019
539
0.510
 Why?
Early Medical Intervention
1
2017
61
0.500
 Why?
Early Diagnosis
2
2017
249
0.490
 Why?
Glatiramer Acetate
6
2019
18
0.480
 Why?
Calcinosis
2
2009
234
0.470
 Why?
Humans
88
2026
144759
0.470
 Why?
Drug Monitoring
1
2019
395
0.460
 Why?
Physicians
4
2016
939
0.460
 Why?
Postural Balance
3
2018
240
0.430
 Why?
Antibodies, Monoclonal, Humanized
8
2023
985
0.400
 Why?
Neuroimaging
2
2026
289
0.370
 Why?
Fatigue
3
2018
366
0.360
 Why?
Dimethyl Fumarate
3
2020
12
0.350
 Why?
Immunoglobulin G
4
2023
893
0.340
 Why?
Multiple Sclerosis, Chronic Progressive
3
2020
28
0.310
 Why?
Practice Guidelines as Topic
1
2018
1560
0.310
 Why?
Middle Aged
39
2025
35875
0.310
 Why?
Withholding Treatment
2
2021
80
0.310
 Why?
Adult
44
2026
40449
0.300
 Why?
Psychiatry
2
2009
193
0.290
 Why?
Demyelinating Diseases
4
2019
84
0.280
 Why?
Cysts
1
2009
111
0.270
 Why?
HIV Long Terminal Repeat
3
2001
11
0.270
 Why?
Education, Medical
1
2011
274
0.260
 Why?
Autoantibodies
3
2023
1501
0.260
 Why?
Lymphopenia
2
2020
65
0.260
 Why?
Certification
1
2008
119
0.260
 Why?
Education
2
2007
104
0.250
 Why?
Central Nervous System Cysts
1
2006
13
0.250
 Why?
Female
49
2025
78271
0.250
 Why?
Cerebral Arteries
1
2006
58
0.240
 Why?
Clinical Trials as Topic
3
2016
1053
0.240
 Why?
Leukoencephalopathies
1
2026
24
0.240
 Why?
Myelin-Oligodendrocyte Glycoprotein
2
2023
53
0.240
 Why?
Single-Blind Method
3
2023
312
0.240
 Why?
Male
40
2025
72315
0.240
 Why?
Cerebrovascular Disorders
1
2006
103
0.230
 Why?
DNA, Viral
2
1998
358
0.230
 Why?
Drug Industry
2
2016
49
0.230
 Why?
Ethics, Medical
2
2015
87
0.230
 Why?
Societies, Medical
4
2019
887
0.220
 Why?
Conflict of Interest
2
2016
52
0.220
 Why?
HIV Seropositivity
2
1998
119
0.220
 Why?
Treatment Outcome
12
2023
11679
0.210
 Why?
White Matter
1
2026
153
0.210
 Why?
Databases, Factual
3
2016
1486
0.210
 Why?
Double-Blind Method
4
2023
2029
0.200
 Why?
AIDS Dementia Complex
3
2001
52
0.200
 Why?
Microglia
2
2024
268
0.190
 Why?
Encephalomyelitis, Autoimmune, Experimental
1
2023
66
0.190
 Why?
Heart Aneurysm
1
2002
12
0.180
 Why?
Quality of Health Care
2
2017
691
0.170
 Why?
Heart Septal Defects, Atrial
1
2002
59
0.170
 Why?
B-Lymphocytes
5
2023
876
0.170
 Why?
Interferon beta-1a
2
2019
14
0.170
 Why?
Lymphoma
2
2005
232
0.170
 Why?
Education, Medical, Continuing
2
2015
132
0.170
 Why?
Central Nervous System Neoplasms
2
2005
173
0.160
 Why?
Mental Disorders
2
2007
1168
0.160
 Why?
Agammaglobulinemia
1
2020
36
0.160
 Why?
Brain Neoplasms
4
2016
1318
0.160
 Why?
Interferon-gamma
1
2023
784
0.160
 Why?
Serum Sickness
1
2019
4
0.150
 Why?
Indans
1
2019
13
0.150
 Why?
Oxadiazoles
1
2019
37
0.150
 Why?
Neutropenia
1
2020
155
0.150
 Why?
Disease Progression
4
2021
2847
0.150
 Why?
Diagnosis, Differential
4
2023
1489
0.150
 Why?
Referral and Consultation
1
2005
851
0.140
 Why?
Lymphoma, AIDS-Related
1
1998
14
0.140
 Why?
Adjuvants, Immunologic
3
2015
245
0.140
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2020
257
0.130
 Why?
Salvage Therapy
1
2019
162
0.130
 Why?
Herpesvirus 8, Human
1
1998
68
0.130
 Why?
Diffuse Cerebral Sclerosis of Schilder
1
2017
4
0.130
 Why?
Eye Movements
1
2018
92
0.130
 Why?
Physician-Patient Relations
2
2016
585
0.130
 Why?
Educational Measurement
3
2015
326
0.130
 Why?
Sarcoma, Kaposi
1
1998
83
0.130
 Why?
Hematopoietic Stem Cell Transplantation
2
2019
675
0.130
 Why?
Central Nervous System
2
2005
281
0.130
 Why?
Patient Selection
2
2015
719
0.130
 Why?
Young Adult
7
2024
14105
0.130
 Why?
Herpesvirus 4, Human
1
2018
176
0.130
 Why?
Herpesviridae Infections
1
1998
150
0.120
 Why?
Nervous System Diseases
2
2024
284
0.120
 Why?
Neurologists
1
2016
22
0.120
 Why?
Suicide, Assisted
1
1997
31
0.120
 Why?
Costs and Cost Analysis
1
2017
219
0.120
 Why?
Estriol
1
2015
6
0.120
 Why?
Cost-Benefit Analysis
2
2016
634
0.120
 Why?
Aged
9
2024
25913
0.120
 Why?
Corpus Callosum
2
2006
72
0.110
 Why?
Verbal Learning
2
2013
73
0.110
 Why?
Dizziness
2
2018
101
0.110
 Why?
T-Lymphocytes
1
2023
1982
0.110
 Why?
Retrospective Studies
10
2024
17066
0.110
 Why?
Follow-Up Studies
6
2020
5408
0.110
 Why?
Diffusion Magnetic Resonance Imaging
2
2006
154
0.100
 Why?
Trust
1
2016
153
0.100
 Why?
Mesenchymal Stem Cell Transplantation
1
2014
59
0.100
 Why?
Medication Reconciliation
1
2013
31
0.100
 Why?
T-Lymphocytes, Helper-Inducer
1
2014
131
0.100
 Why?
CD40 Antigens
1
2014
90
0.100
 Why?
Insurance, Health
1
2016
302
0.100
 Why?
JC Virus
1
2013
23
0.100
 Why?
Exercise Therapy
1
2018
473
0.100
 Why?
Anti-Inflammatory Agents
2
2006
474
0.100
 Why?
Stroke
1
2002
1256
0.100
 Why?
Sensation Disorders
1
2012
41
0.090
 Why?
Immune Reconstitution Inflammatory Syndrome
1
2012
20
0.090
 Why?
Population Surveillance
1
2016
485
0.090
 Why?
Memory Disorders
1
2013
193
0.090
 Why?
Immunoglobulin Heavy Chains
3
2007
85
0.090
 Why?
Leukoencephalopathy, Progressive Multifocal
1
2012
38
0.090
 Why?
Lymphoma, T-Cell, Peripheral
1
2012
20
0.090
 Why?
HIV-1
2
2001
896
0.090
 Why?
Optic Nerve
2
2005
67
0.090
 Why?
T-Lymphocyte Subsets
1
2014
415
0.090
 Why?
Glioma
1
2016
425
0.090
 Why?
Gadolinium
4
2018
84
0.080
 Why?
United States
8
2024
15966
0.080
 Why?
Academies and Institutes
1
2011
60
0.080
 Why?
Self-Assessment
1
2011
74
0.080
 Why?
Nerve Regeneration
1
2010
56
0.080
 Why?
Learning
1
2015
452
0.080
 Why?
Fatal Outcome
3
2006
307
0.080
 Why?
Leukocytosis
1
2010
32
0.080
 Why?
Diagnostic Tests, Routine
1
2011
108
0.080
 Why?
Antigens, CD19
3
2007
129
0.080
 Why?
Cranial Nerve Neoplasms
1
1989
7
0.080
 Why?
Hemangioma, Cavernous
1
1989
13
0.080
 Why?
Optic Chiasm
1
1989
18
0.080
 Why?
Central Nervous System Infections
1
2010
35
0.080
 Why?
Biomarkers
3
2014
4271
0.080
 Why?
Exercise Test
1
2012
634
0.080
 Why?
Severity of Illness Index
3
2014
2925
0.070
 Why?
Quality of Life
3
2021
3185
0.070
 Why?
Disease Management
1
2013
645
0.070
 Why?
Guidelines as Topic
1
2011
267
0.070
 Why?
Spinal Cord
3
2023
380
0.070
 Why?
Neuroprotective Agents
1
2009
143
0.070
 Why?
Physical Therapy Modalities
1
2011
332
0.070
 Why?
Hospital-Physician Relations
1
2007
3
0.070
 Why?
Immunoglobulin Variable Region
2
2004
80
0.060
 Why?
Practice Patterns, Physicians'
1
2016
1356
0.060
 Why?
Workload
1
2009
170
0.060
 Why?
Vasculitis, Central Nervous System
1
2006
16
0.060
 Why?
Headache Disorders
1
2006
19
0.060
 Why?
Nerve Fibers, Myelinated
1
2006
47
0.060
 Why?
CD4-Positive T-Lymphocytes
1
1993
1129
0.060
 Why?
Neuropsychological Tests
2
2013
1134
0.060
 Why?
Antibodies, Monoclonal
2
2011
1519
0.060
 Why?
Methylprednisolone
1
2006
64
0.060
 Why?
Medical Records
1
2007
187
0.060
 Why?
Syndrome
2
2023
380
0.060
 Why?
Antibody Formation
1
2007
294
0.060
 Why?
Huntington Disease
1
2007
61
0.060
 Why?
Glial Fibrillary Acidic Protein
1
2006
124
0.060
 Why?
International Classification of Diseases
1
2007
147
0.060
 Why?
Herpes Zoster
1
2010
315
0.060
 Why?
Intracranial Hemorrhages
1
2006
100
0.060
 Why?
Contrast Media
3
2018
488
0.060
 Why?
Aquaporin 4
1
2006
98
0.060
 Why?
DNA Mutational Analysis
1
2006
406
0.060
 Why?
Adolescent
8
2024
22428
0.060
 Why?
Canada
2
2019
428
0.060
 Why?
Health Care Surveys
1
2007
539
0.060
 Why?
Analysis of Variance
3
2015
1306
0.050
 Why?
Neurologic Examination
1
2005
131
0.050
 Why?
Patient Compliance
1
2009
588
0.050
 Why?
Teaching
1
2007
236
0.050
 Why?
Cognition Disorders
1
2009
538
0.050
 Why?
Fellowships and Scholarships
1
2009
357
0.050
 Why?
RNA, Messenger
1
1992
2832
0.050
 Why?
Surveys and Questionnaires
4
2016
6048
0.050
 Why?
Program Evaluation
1
2009
948
0.050
 Why?
Central Nervous System Diseases
1
2005
74
0.050
 Why?
Colorado
2
2024
4564
0.050
 Why?
Affect
1
2007
318
0.050
 Why?
Simvastatin
1
2004
60
0.050
 Why?
Neutrophils
1
2010
1134
0.050
 Why?
Erythrocytes
1
2010
757
0.050
 Why?
Ophthalmoplegia
1
2003
13
0.050
 Why?
Proteoglycans
1
2004
110
0.050
 Why?
Prevalence
2
2024
2834
0.050
 Why?
Diagnostic Techniques, Ophthalmological
1
2003
53
0.050
 Why?
Faculty, Medical
1
2006
302
0.050
 Why?
B-Lymphocyte Subsets
1
2003
80
0.050
 Why?
Cyclophosphamide
1
2003
266
0.050
 Why?
Radiography
1
2005
844
0.050
 Why?
Neurodegenerative Diseases
1
2024
151
0.050
 Why?
Patient Outcome Assessment
1
2023
134
0.040
 Why?
Infusions, Intravenous
1
2023
423
0.040
 Why?
Academic Medical Centers
1
2005
547
0.040
 Why?
Membrane Glycoproteins
1
2004
496
0.040
 Why?
Lymphoma, B-Cell
2
2005
132
0.040
 Why?
Students, Medical
1
2006
375
0.040
 Why?
Pain
1
2007
779
0.040
 Why?
Induced Pluripotent Stem Cells
1
2024
276
0.040
 Why?
Anticoagulants
1
2006
722
0.040
 Why?
CCAAT-Enhancer-Binding Proteins
1
2001
38
0.040
 Why?
Molecular Sequence Data
3
2004
2930
0.040
 Why?
Disability Evaluation
2
2014
310
0.040
 Why?
Single-Cell Analysis
1
2024
358
0.040
 Why?
Antibodies, Antinuclear
1
2001
62
0.040
 Why?
Schools, Medical
1
2002
156
0.040
 Why?
Peptides
3
2013
995
0.040
 Why?
Cross-Sectional Studies
1
2012
5868
0.040
 Why?
Atrophy
1
2021
201
0.040
 Why?
Dementia
1
2005
303
0.040
 Why?
Time Factors
4
2018
7173
0.040
 Why?
Proteasome Endopeptidase Complex
1
2001
159
0.040
 Why?
Mobility Limitation
1
2020
66
0.040
 Why?
Clinical Competence
1
2008
1244
0.040
 Why?
Venous Thrombosis
1
2002
194
0.040
 Why?
Child
5
2016
22633
0.040
 Why?
Interferon-beta
2
2011
92
0.040
 Why?
Lymphocyte Activation
1
2003
1126
0.040
 Why?
Antibodies, Viral
1
2023
672
0.040
 Why?
Maintenance Chemotherapy
1
2019
42
0.040
 Why?
Cell Separation
2
2014
307
0.040
 Why?
Cerebral Infarction
1
1998
47
0.040
 Why?
Induction Chemotherapy
1
2019
87
0.040
 Why?
Lipids
1
2023
710
0.030
 Why?
HIV Seronegativity
1
1998
29
0.030
 Why?
Genes, myc
1
1998
50
0.030
 Why?
Base Sequence
2
2001
2190
0.030
 Why?
Transplantation, Autologous
1
2019
290
0.030
 Why?
Astrocytoma
1
1998
129
0.030
 Why?
In Situ Hybridization
1
2018
319
0.030
 Why?
Gene Library
1
1997
126
0.030
 Why?
Real-Time Polymerase Chain Reaction
1
2018
341
0.030
 Why?
Gene Rearrangement
1
1998
155
0.030
 Why?
Risk Assessment
1
2006
3671
0.030
 Why?
Managed Care Programs
1
1997
138
0.030
 Why?
Syndecan-1
2
2007
42
0.030
 Why?
Drug Administration Schedule
1
2018
779
0.030
 Why?
Morals
1
1997
80
0.030
 Why?
Flow Cytometry
2
2014
1173
0.030
 Why?
Breast Neoplasms
1
2008
2452
0.030
 Why?
Risk Factors
3
2008
10779
0.030
 Why?
Viral Load
1
2018
526
0.030
 Why?
Mutation
1
2006
4089
0.030
 Why?
Polymerase Chain Reaction
1
1998
1054
0.030
 Why?
Survival Analysis
1
2018
1382
0.030
 Why?
Sequence Analysis, DNA
1
1997
824
0.030
 Why?
Health Knowledge, Attitudes, Practice
2
2016
1414
0.030
 Why?
Child, Preschool
3
2016
11787
0.020
 Why?
Incidence
1
2020
2879
0.020
 Why?
Congresses as Topic
1
2015
221
0.020
 Why?
Propylene Glycols
1
2013
27
0.020
 Why?
Ocular Physiological Phenomena
1
1992
10
0.020
 Why?
HLA-DR Antigens
1
2014
220
0.020
 Why?
Patient Care Team
1
2019
689
0.020
 Why?
Sphingosine
1
2013
45
0.020
 Why?
beta-Galactosidase
1
1992
77
0.020
 Why?
Quality-Adjusted Life Years
1
2013
121
0.020
 Why?
Drug Therapy, Combination
1
2015
1047
0.020
 Why?
Markov Chains
1
2013
129
0.020
 Why?
Leukocyte Count
1
1993
316
0.020
 Why?
Mice, Inbred DBA
1
1992
187
0.020
 Why?
Haplotypes
1
2014
490
0.020
 Why?
Organ Specificity
1
1992
312
0.020
 Why?
Reference Values
1
2013
797
0.020
 Why?
Comparative Effectiveness Research
1
2013
170
0.020
 Why?
CD3 Complex
1
2012
111
0.020
 Why?
Ki-67 Antigen
1
2012
117
0.020
 Why?
Thymus Gland
1
1992
311
0.020
 Why?
Mental Recall
1
2013
222
0.020
 Why?
Intestine, Small
1
1992
166
0.020
 Why?
Mitoxantrone
1
2011
15
0.020
 Why?
Hematologic Tests
1
2011
21
0.020
 Why?
Mice
2
2023
18339
0.020
 Why?
Muscle Stretching Exercises
1
2011
19
0.020
 Why?
Animals
3
2023
38058
0.020
 Why?
Patient Participation
1
2015
431
0.020
 Why?
Clinical Laboratory Techniques
1
2011
96
0.020
 Why?
Depression
2
2011
1558
0.020
 Why?
Recombinant Fusion Proteins
1
1992
675
0.020
 Why?
Amino Acid Sequence
2
2004
2155
0.020
 Why?
Physical Endurance
1
2011
278
0.020
 Why?
Acyclovir
1
2010
96
0.020
 Why?
Spinal Cord Neoplasms
1
1989
41
0.020
 Why?
Cell Count
1
2010
320
0.020
 Why?
Respiratory Function Tests
1
2011
547
0.020
 Why?
History, 19th Century
1
2009
61
0.020
 Why?
Randomized Controlled Trials as Topic
2
2006
1720
0.020
 Why?
Neoplasms, Multiple Primary
1
1989
58
0.020
 Why?
Aged, 80 and over
2
2016
8265
0.020
 Why?
Injections
1
2009
196
0.020
 Why?
History, 21st Century
1
2009
219
0.020
 Why?
Autoimmunity
1
2014
926
0.020
 Why?
Pilot Projects
2
2004
1886
0.020
 Why?
History, 20th Century
1
2009
325
0.020
 Why?
Electrocardiography
1
2011
662
0.020
 Why?
Gene Expression
1
1992
1490
0.020
 Why?
Mice, Transgenic
1
1992
2182
0.020
 Why?
Health
1
2007
81
0.020
 Why?
Age of Onset
1
2009
551
0.020
 Why?
Memory
1
2009
295
0.020
 Why?
Association Learning
1
2007
71
0.020
 Why?
Walking
1
2011
545
0.020
 Why?
Herpesvirus 3, Human
1
2010
336
0.020
 Why?
Cerebral Ventricles
1
2006
54
0.020
 Why?
CD8-Positive T-Lymphocytes
1
2012
917
0.010
 Why?
Prognosis
2
2006
4282
0.010
 Why?
Motor Skills
1
2007
104
0.010
 Why?
Hypothalamus
1
2006
153
0.010
 Why?
Phenotype
1
2014
3162
0.010
 Why?
Genetics
1
2005
23
0.010
 Why?
Models, Theoretical
1
2009
582
0.010
 Why?
Immunologic Memory
1
2007
366
0.010
 Why?
Neurosciences
1
2005
25
0.010
 Why?
Syndecans
1
2004
5
0.010
 Why?
Social Support
1
2009
652
0.010
 Why?
Anisotropy
1
2004
75
0.010
 Why?
Hospitalization
1
2015
2433
0.010
 Why?
Clinical Protocols
1
2006
282
0.010
 Why?
Image Interpretation, Computer-Assisted
1
2006
285
0.010
 Why?
Immune System
1
2005
179
0.010
 Why?
Internet
1
2009
699
0.010
 Why?
Plasma Cells
1
2004
75
0.010
 Why?
Gene Rearrangement, B-Lymphocyte, Light Chain
1
2003
4
0.010
 Why?
Antiviral Agents
1
2010
767
0.010
 Why?
Gene Rearrangement, B-Lymphocyte, Heavy Chain
1
2003
11
0.010
 Why?
Meningitis, Viral
1
2003
20
0.010
 Why?
Infrared Rays
1
2003
27
0.010
 Why?
Videotape Recording
1
2003
37
0.010
 Why?
Saccades
1
2003
45
0.010
 Why?
Antilymphocyte Serum
1
2003
61
0.010
 Why?
Oligoclonal Bands
1
2003
26
0.010
 Why?
Antigens, CD34
1
2003
88
0.010
 Why?
Clone Cells
1
2003
266
0.010
 Why?
Whole-Body Irradiation
1
2003
76
0.010
 Why?
Astrocytes
1
2005
222
0.010
 Why?
Receptors, Antigen, B-Cell
1
2003
134
0.010
 Why?
Immunoglobulins
1
2003
160
0.010
 Why?
Observer Variation
1
2003
355
0.010
 Why?
Lymphoma, Large B-Cell, Diffuse
1
2005
192
0.010
 Why?
Feasibility Studies
1
2006
1095
0.010
 Why?
ATPases Associated with Diverse Cellular Activities
1
2001
9
0.010
 Why?
Mice, Inbred C57BL
1
1992
5992
0.010
 Why?
Administration, Oral
1
2004
847
0.010
 Why?
Age Factors
1
2009
3333
0.010
 Why?
Tomography, X-Ray Computed
1
2012
2730
0.010
 Why?
Consensus Sequence
1
2001
74
0.010
 Why?
Biopsy
1
2005
1075
0.010
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2003
983
0.010
 Why?
Longitudinal Studies
1
2009
2947
0.010
 Why?
Sex Characteristics
1
2007
790
0.010
 Why?
Cytomegalovirus Infections
1
2003
206
0.010
 Why?
Immunoglobulin kappa-Chains
1
2001
23
0.010
 Why?
Immunoglobulin Fab Fragments
1
2001
56
0.010
 Why?
Urinary Tract Infections
1
2003
202
0.010
 Why?
Gene Expression Regulation, Viral
1
2001
94
0.010
 Why?
Infant
1
2015
10034
0.010
 Why?
Cohort Studies
1
2011
5960
0.010
 Why?
Predictive Value of Tests
1
2006
2115
0.010
 Why?
Acute Disease
1
2003
1030
0.010
 Why?
Research
1
2003
431
0.010
 Why?
Combined Modality Therapy
1
2003
1266
0.010
 Why?
Lung
1
1992
4109
0.010
 Why?
Arachnoid
1
1998
11
0.010
 Why?
Sensitivity and Specificity
1
2003
1985
0.010
 Why?
Monocytes
1
2001
538
0.010
 Why?
Survival Rate
1
2003
2089
0.010
 Why?
Virus Replication
1
2001
529
0.010
 Why?
Binding Sites
1
2001
1329
0.010
 Why?
Models, Biological
1
2005
1821
0.010
 Why?
Case-Control Studies
1
2004
3604
0.010
 Why?
Aging
1
2007
1966
0.010
 Why?
Reproducibility of Results
1
2003
3409
0.010
 Why?
Transcription, Genetic
1
2001
1496
0.010
 Why?
DNA-Binding Proteins
1
2001
1499
0.010
 Why?
Cells, Cultured
1
2001
4154
0.010
 Why?
Corboy's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (393) concept(s)
_
Co-Authors Expand Description
See all (38) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)